Sudarshawn Damodharan to Immunotherapy, Adoptive
This is a "connection" page, showing publications Sudarshawn Damodharan has written about Immunotherapy, Adoptive.
Connection Strength
0.052
-
Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood Adv. 2024 08 13; 8(15):4164-4168.
Score: 0.052